Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5-6
|
| pubmed:dateCreated |
1999-2-18
|
| pubmed:abstractText |
Severe hypertriglyceridemia is a risk factor for acute pancreatitis, therefore decreasing serum triglyceride concentrations is an important component of risk management. Omega-3 fatty acids are well known hypotriglyceridemic agents, but their efficacy in severe forms of the disorder is not well documented. Our objective was to examine the effects of Omacor, a drug composed of 85% omega-3 fatty acid ethyl esters.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
1350-6277
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
4
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
385-91
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:9865671-Cholesterol,
pubmed-meshheading:9865671-Double-Blind Method,
pubmed-meshheading:9865671-Fatty Acids, Omega-3,
pubmed-meshheading:9865671-Female,
pubmed-meshheading:9865671-Humans,
pubmed-meshheading:9865671-Hypertriglyceridemia,
pubmed-meshheading:9865671-Male,
pubmed-meshheading:9865671-Middle Aged,
pubmed-meshheading:9865671-Prospective Studies,
pubmed-meshheading:9865671-Triglycerides
|
| pubmed:articleTitle |
Safety and efficacy of Omacor in severe hypertriglyceridemia.
|
| pubmed:affiliation |
Department of Medicine, University of Kansas Medical Center, Kansas City, USA.
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|